Your browser doesn't support javascript.
loading
[The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic].
Avdeev, S N; Chulanov, V P; Alexeeva, E I; Aleshina, O A; Bereznikov, A V; Kotenko, O N; Lila, A M; Mutovina, Z Y; Parovichnikova, E N; Fomina, D S; Frolova, N F; Shevchenko, A O.
Afiliação
  • Avdeev SN; Sechenov First Moscow State Medical University (Sechenov University).
  • Chulanov VP; Sechenov First Moscow State Medical University (Sechenov University).
  • Alexeeva EI; National Medical Research Center for Phthisiopulmonology and Infectious Diseases.
  • Aleshina OA; Sechenov First Moscow State Medical University (Sechenov University).
  • Bereznikov AV; National Medical Research Center for Children's Health.
  • Kotenko ON; National Medical Research Center for Hematology.
  • Lila AM; AlfaStrakhovanie-OMS LLC.
  • Mutovina ZY; ROSBIOTECH University.
  • Parovichnikova EN; City Clinical Hospital №52.
  • Fomina DS; Pirogov Russian National Research Medical University.
  • Frolova NF; Nasonova Research Institute of Rheumatology.
  • Shevchenko AO; Russian Medical Academy of Continuous Professional Education.
Ter Arkh ; 95(8): 722-729, 2023 Oct 11.
Article em Ru | MEDLINE | ID: mdl-38158913
ABSTRACT
On July 3, 2023, an interdisciplinary Council of Experts "The burden of COVID-19 in a heterogeneous population of immunocompromised patients - post-pandemic realities" was held in Moscow with leading experts in pulmonology, rheumatology, hematology, oncology, nephrology, allergology-immunology, transplantation, and infectious diseases. The aim of the meeting was to discuss the current clinical and epidemiologic situation related to COVID-19, the relevance of disease prevention strategies for high-risk patients. The experts addressed the following issues 1) the disease burden of COVID-19 in 2023 for patients with immunodeficiency in different therapeutic areas; 2) the place of passive immunization with monoclonal antibodies as a method of COVID-19 prophylaxis among immunocompromised patients; 3) prerequisites for the inclusion of passive immunization of immunocompromised patients into routine clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reumatologia / COVID-19 Idioma: Ru Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reumatologia / COVID-19 Idioma: Ru Ano de publicação: 2023 Tipo de documento: Article